Scynexis SCYX
NASDAQ SCYX
$4.91 -0.24 (-4.66%)
At close: Sep 9, 2026 · 4:00 PM EDT

Scynexis (SCYX) Cash from Restructuring (2014 - 2016)

Scynexis' (SCYX) quarterly Cash from Restructuring came in at -$8000.0 in Q4 2016, up 96.23% quarter-over-quarter from -$212000.0 in Q3 2016.

Analysis

Scynexis (SCYX) Cash from Restructuring (2014 - 2016) Analysis & Trends

Scynexis (SCYX) has reported Cash from Restructuring for 3 consecutive years, with -$8000.0 the latest figure, recorded in Q4 2016.

  • For the quarter ending Q4 2016, Cash from Restructuring changed N/A year-over-year to -$8000.0; the trailing twelve-month figure through Sep 2017 stood at -$8000.0 (up 99.39% YoY), and the FY2016 full-year result was -$2.6 million, changed N/A from the prior year.
  • Cash from Restructuring improved to -$8000.0 in Q4 2016 per SCYX's latest filing, from -$212000.0 in the prior quarter.
  • Across five years, Cash from Restructuring topped out at $1.5 million in Q2 2015 and bottomed at -$1.8 million in Q1 2016.
  • Historically, Cash from Restructuring has averaged -$31285.7 across 3 years, with a median of -$212000.0 in 2016.
  • The sharpest annual moves came in 2015 and 2016: Cash from Restructuring soared 436.76% in 2015, then tumbled 140.69% in 2016.
  • Over 3 years, Cash from Restructuring stood at -$389000.0 in 2014, then jumped by 436.76% to $1.3 million in 2015, then sank by 100.61% to -$8000.0 in 2016.
  • According to Business Quant data, Cash from Restructuring over the past three periods registered -$8000.0, -$212000.0, and -$610000.0 for Q4 2016, Q3 2016, and Q2 2016 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn
10 Scynexis 58.41 Mn -56.29 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 -8,000.00
Sep 30, 2016 -212,000.00
Jun 30, 2016 -610,000.00
Mar 31, 2016 -1.81 Mn
Sep 30, 2015 1.31 Mn
Jun 30, 2015 1.50 Mn
Sep 30, 2014 -389,000.00